The New York Stem Cell Foundation Research Institute’s Post

In a recent interview, we spoke with Jennifer D Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP, on the role of lipid management in diabetes care Learn more: https://lnkd.in/grCng5JD #Cholesterol #Diabetes

"📚 Breaking Research News! In a recent study published in the English Journal of Medicine, shocking results reveal a medicine that not only failed but *increased* diabetes risk! Uncover the details and explore better, safer alternatives in this eye-opening video. Watch now! #MedicalStudyRevelations #DiabetesAwareness#diabetestipo2 #diabetes1 #diabetestipo2#diabetessucks #diabetesreversal #insulin #Weighosstransformation

Can Intermittent Fasting Reverse Type 2 Diabetes? via the IF Insider | Dr. Ellen Britt & Denise Wakeman We take a look at a 2019 review study published in the Journal of Clinical Medicine https://lttr.ai/AKfvi #intermittentfasting #diabetes #fastingresults

Did you know that 8.8% of adults in Wisconsin have diabetes, and an additional 34% are pre-diabetic? 💉 ⚕ With AHW Seed Grant Funding 🌱, Medical College of Wisconsin researchers are investigating how changes in cell structure affect the genes that control glucose production--hopefully paving the way for new diabetes treatments and to improve lives. Learn more about the project here: https://lnkd.in/gBugKtRB #AHWEndowment #WisconsinHealth #Diabetes #DiabetesResearch

Join fellow clinical professionals at the Hoag Diabetes: What’s New? What’s Next? Conference. This knowledge-based, one-day conference will focus on comprehensive and innovative clinical and psychosocial approaches for the management of prediabetes and diabetes across the lifespan, emerging technologies in insulin delivery and glucose monitoring, gestational diabetes, and weight management in the treatment of diabetes. Register at https://lnkd.in/gd4tw2FT. #Diabetes #EmpoweredbyHoag

Join fellow clinical professionals at the Hoag Diabetes: What’s New? What’s Next? Conference. This knowledge-based, one-day conference will focus on comprehensive and innovative clinical and psychosocial approaches for management of prediabetes and diabetes across the lifespan, emerging technologies in insulin delivery and glucose monitoring, gestational diabetes, and weight management in the treatment of diabetes. Register at https://lnkd.in/gd4tw2FT. #Diabetes #EmpoweredbyHoag

📣NEW‼️: First accuracy and user-experience evaluation of new continuous glucose monitoring (CGM) system for hypoglycemia due to hyperinsulinism, published in the Journal of Diabetes Science and Technology (JDST). The authors of this important evaluation are all members of the expert staff at the Royal Manchester Children's Hospital which is a CHI Center of Excellence. The Manchester team found improvements in user experience for the latest Dexcom CGM model. Visit https://lnkd.in/eS9hvqu2 to read more. #hyperinsulinism #raredisease #congenitalhyperinsulinism #hypoglycemia | Hyperinsulinism | Congenital | HI | Hypoglycemia | Rare Disease

Reduced incretin effect precedes diabetes development following duodenopancreatectomy in individuals without diabetes Open access in The Journal of Clinical Investigation: https://lnkd.in/dvFAbncv

An interesting perspective accompanies the article in Science https://lnkd.in/dzBxCRBd

Impacting around 14% of #pregnancies worldwide, gestational #diabetes is rising alongside obesity and type 2 diabetes. A new paper co-authored by Magee-Womens investigator Dr. Maisa Feghali explores the complexities of gestational diabetes and the urgent need for a life course precision medicine approach. With the direct costs of gestational diabetes reaching $1.6 billion in the USA alone, it's crucial to adopt evidence-based strategies for prevention, diagnosis, and treatment. 🔗 Read the full paper here: https://bit.ly/3WCxqs4